Literature DB >> 9560256

On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor beta chain.

F Wang1, T Ono, A M Kalergis, W Zhang, T P DiLorenzo, K Lim, S G Nathenson.   

Abstract

The specificity of T cell-mediated immune responses is primarily determined by the interaction between the T cell receptor (TCR) and the antigenic peptide presented by the major histocompatibility complex (MHC) molecules. To refine our understanding of interactions between the TCR and the antigenic peptide of vesicular stomatitis virus (VSV) presented by the class I MHC molecule H-2Kb, we constructed a TCR alpha chain transgenic mouse in a TCR alpha-deficient background to define specific structural features in the TCR beta chain that are important for the recognition of the VSV/H-2Kb complex. We found that for a given peptide, a peptide-specific, highly conserved amino acid could always be identified at position 98 of the complementarity-determining region 3 (CDR3) loop of TCR beta chains. Further, we demonstrated that substitutions at position 6, but not position 1, of the VSV peptide induced compensatory changes in the TCR in both the amino acid residue at position 98 and the length of the CDR3beta loop. We conclude that the amino acid residue at position 98 of the CDR3beta loop is a key residue that plays a critical role in determining the specificity of TCR-VSV/H-2Kb interactions and that a specific length of the CDR3beta loop is required to facilitate such interactions. Further, these findings suggest that the alpha and beta chains of TCRs interact with amino acid residue(s) toward the N and C termini of the VSV peptide, respectively, providing functional evidence for the orientation of a TCR with its peptide/MHC ligand as observed in the crystal structures of TCR/peptide/MHC complexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560256      PMCID: PMC20241          DOI: 10.1073/pnas.95.9.5217

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Implications of a Fab-like structure for the T-cell receptor.

Authors:  J M Claverie; A Prochnicka-Chalufour; L Bougueleret
Journal:  Immunol Today       Date:  1989-01

2.  Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.

Authors:  G M Van Bleek; S G Nathenson
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

Review 3.  Developmental biology of T cells in T cell-receptor transgenic mice.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  T cell receptor gene diversity and selection.

Authors:  M M Davis
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

5.  A T cell clone expresses two T cell receptor alpha genes but uses one alpha beta heterodimer for allorecognition and self MHC-restricted antigen recognition.

Authors:  M Malissen; J Trucy; F Letourneur; N Rebaï; D E Dunn; F W Fitch; L Hood; B Malissen
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

6.  Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody.

Authors:  J Wang; K Lim; A Smolyar; M Teng; J Liu; A G Tse; J Liu; R E Hussey; Y Chishti; C T Thomson; R M Sweet; S G Nathenson; H C Chang; J C Sacchettini; E L Reinherz
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

7.  T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes.

Authors:  H Blüthmann; P Kisielow; Y Uematsu; M Malissen; P Krimpenfort; A Berns; H von Boehmer; M Steinmetz
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  Expression of T-cell receptor alpha-chain genes in transgenic mice.

Authors:  L J Berg; B Fazekas de St Groth; F Ivars; C C Goodnow; S Gilfillan; H J Garchon; M M Davis
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

9.  The outline structure of the T-cell alpha beta receptor.

Authors:  C Chothia; D R Boswell; A M Lesk
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  The V beta 17+ T cell repertoire: skewed J beta usage after thymic selection; dissimilar CDR3s in CD4+ versus CD8+ cells.

Authors:  S Candéias; C Waltzinger; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  7 in total

1.  Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.

Authors:  J L Matsuda; L Gapin; N Fazilleau; K Warren; O V Naidenko; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

Review 2.  Peptides for Vaccine Development.

Authors:  Ian W Hamley
Journal:  ACS Appl Bio Mater       Date:  2022-02-23

3.  Qualitative differences in brain-infiltrating T cells are associated with a fatal outcome in mice infected with Japanese encephalitis virus.

Authors:  Kenji Shirai; Daisuke Hayasaka; Kazutaka Kitaura; Tomohiko Takasaki; Kouichi Morita; Ryuji Suzuki; Ichiro Kurane
Journal:  Arch Virol       Date:  2015-01-22       Impact factor: 2.574

4.  Characterization of amino acid residues of T-cell receptors interacting with HLA-A*02-restricted antigen peptides.

Authors:  Ying Zhu; Changxin Huang; Meng Su; Zuanmin Ge; Lanlan Gao; Yanfei Shi; Xuechun Wang; Jianfeng Chen
Journal:  Ann Transl Med       Date:  2021-03

Review 5.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07

Review 6.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

7.  An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.

Authors:  C V Herst; S Burkholz; J Sidney; A Sette; P E Harris; S Massey; T Brasel; E Cunha-Neto; D S Rosa; W C H Chao; R Carback; T Hodge; L Wang; S Ciotlos; P Lloyd; R Rubsamen
Journal:  Vaccine       Date:  2020-04-28       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.